omicron
News
2023.04.17
Launched in October 2020, the ComCor study investigates the environment, practices and places visited by people recently infected with SARS-CoV-2. The aim is...
News
2023.02.20
The availability of SARS-CoV-2 vaccines and the first antiviral drugs at the end of 2020 led to a reduction in the number of infections and the severity of...
Document de presse
2022.10.21
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by...
News
2022.07.09
Institut Pasteur Senior Executive Scientific Vice-President Christophe d'Enfert provides a brief, cross-disciplinary overview of 2021 covering capacity...
News
2022.07.11
Following the release of the 2021 edition of the Institut Pasteur's Annual Report, here are some of the year's highlights. Twelve eventful months interspersed...
News
2022.07.08
Institut Pasteur Board of Governors Chairman Christian Vigouroux and President Prof. Sir Stewart Cole share their thoughts on the year's highlights. 2021 was a...
News
2022.07.05
Several factors determine the evolutionary success of SARS-CoV-2 variants of concern. A recent publication looks into the factors influencing this success –...
News
2022.07.01
As a first-line laboratory in the event of a health emergency, the Pasteur Center in Cameroon was naturally designated as a COVID-19 reference laboratory by...
News
2022.02.16
With the emergence of the Omicron variant, healthcare facilities remain highly vulnerable to virus spread. Effective surveillance of viral presence in these...
Document de presse
2021.12.23
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the...